Targeting microtubules sensitizes drug resistant lung cancer cells to lysosomal pathway inhibitors.
Saved in:
| Title: | Targeting microtubules sensitizes drug resistant lung cancer cells to lysosomal pathway inhibitors. |
|---|---|
| Authors: | Chin TM; Cancer Science Institute, National University of Singapore, 14 Medical Drive, Singapore 117599.; National University Health System, 5 Lower Kent Ridge Road, Singapore 119074.; Parkway Cancer Centre, Gleneagles Hospital. 6A Napier Road, Singapore 258500., Boopathy GTK; Cancer Science Institute, National University of Singapore, 14 Medical Drive, Singapore 117599.; Institute of Molecular and Cell Biology, Agency for Science, Technology and Research (ASTAR), 61 Biopolis Drive, Proteos, Singapore 138673., Man EPS; Cancer Science Institute, National University of Singapore, 14 Medical Drive, Singapore 117599., Clohessy JG; Harvard Stem Cell Institute, Harvard Medical School, Boston, MA 02115., Csizmadia E; Harvard Stem Cell Institute, Harvard Medical School, Boston, MA 02115., Quinlan MP; Massachusetts General Hospital Cancer Center, 149 13th Street, Charlestown, MA 02129., Putti T; National University Health System, 5 Lower Kent Ridge Road, Singapore 119074., Wan SC; Cancer Science Institute, National University of Singapore, 14 Medical Drive, Singapore 117599., Xie C; Cancer Science Institute, National University of Singapore, 14 Medical Drive, Singapore 117599., Ali A; Cancer Science Institute, National University of Singapore, 14 Medical Drive, Singapore 117599., Wai FC; Cancer Science Institute, National University of Singapore, 14 Medical Drive, Singapore 117599., Ong YS; Institute of Molecular and Cell Biology, Agency for Science, Technology and Research (ASTAR), 61 Biopolis Drive, Proteos, Singapore 138673., Goh BC; Cancer Science Institute, National University of Singapore, 14 Medical Drive, Singapore 117599.; National University Health System, 5 Lower Kent Ridge Road, Singapore 119074., Settleman J; Massachusetts General Hospital Cancer Center, 149 13th Street, Charlestown, MA 02129.; Current address for Jeff Settleman: Pfizer, Inc. 10646 Science Center Drive, San Diego, CA 92121., Hong W; Institute of Molecular and Cell Biology, Agency for Science, Technology and Research (ASTAR), 61 Biopolis Drive, Proteos, Singapore 138673., Levantini E; Harvard Stem Cell Institute, Harvard Medical School, Boston, MA 02115.; Institute of Biomedical Technologies, National Research Council (CNR), Pisa, Italy., Tenen DG; Cancer Science Institute, National University of Singapore, 14 Medical Drive, Singapore 117599.; Harvard Stem Cell Institute, Harvard Medical School, Boston, MA 02115. |
| Source: | Theranostics [Theranostics] 2020 Feb 03; Vol. 10 (6), pp. 2727-2743. Date of Electronic Publication: 2020 Feb 03 (Print Publication: 2020). |
| Publication Type: | Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Ivyspring International Publisher Country of Publication: Australia NLM ID: 101552395 Publication Model: eCollection Cited Medium: Internet ISSN: 1838-7640 (Electronic) Linking ISSN: 18387640 NLM ISO Abbreviation: Theranostics Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
